Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger - 06/10/17
Doi : 10.1016/S0190-9622(87)70170-4
Sandy S. Milgraum, M.D. *, Andrew J. Mitchell, M.D. **, George E. Bacon, M.D. ***, ****, James E. Rasmussen, M.D. *, ⁎
a Ann Arbor, MI, USA
b Detroit, MI, USA
†Reprint requests to: Dr. James E. Rasmussen, Department of Dermatology, 1910 Taubman Health Care Center, University of Michigan Hospitals, 1500 East Medical Center Dr., Ann Arbor, MI 48109-0314.
Résumé |
Forty-five children with alopecia areata were prospectively studied by means of both clinical and laboratory evaluation for evidence of endocrine diseases and autoantibodies. Twenty-four percent had an abnormality as determined by one or more thyroid function studies (thyroxine, triiodothyronine, and thyroid-stimulating hormone) and/or elevation of microsomal antibody levels. In 16%, smooth muscle antibody was present, and in 4%, parietal cell antibody was present. Routine thyroid function testing is recommended for all children with alopecia areata.
Le texte complet de cet article est disponible en PDF.© 1987
Publié par Elsevier Masson SAS.
Vol 17 - N° 1
P. 57-61 - juillet 1987 Retour au numéro
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?